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Summary
The sperm protein fertilinb, a member of the ADAM
family of proteins, is implicated in sperm-egg binding
in all mammals studied to date. Multivalent inhibitors
containing the three amino acid binding sequence of
fertilinb, ECD, have been shown previously to be
more effective inhibitors of fertilization than their
monovalent counterparts. Here, we probed sperm-
egg interactions with ruthenium-catalyzed ring-open-
ing metathesis polymers that contained from 3 to 70
ECD pharmacophores in densities ranging from 10%
to 100%. Evaluation of the polymer potencies, and
synthesis of a triblock copolymer from two building
blocks, revealed that two multivalent contacts are
sufficient for maximal inhibition, and that the distance
between ECD pharmacophores required is 7–9 mono-
mers spanning 4–5 nm. We conclude that inhibition
requires recruitment of two receptors on the egg
surface into an inhibitory complex.
Introduction
Fertilization of a mammalian oocyte by a single sperm is
an extremely complex event. Many of the protein-protein
and protein-carbohydrate interactions in the pathway
are still unknown. The organization, localization, and
binding properties of receptor-ligand complexes be-
tween sperm and egg still need to be characterized. Elu-
cidation of the pathway and the mechanisms involved is
critical for the design and synthesis of pharmaceuticals,
which target population control and treat infertility.
Sperm-egg recognition, binding, and fusion events are
dictated by a variety of multivalent receptor-ligand con-
tacts. Using ring-opening metathesis polymerization
(ROMP), we have developed synthetic ligands that mimic
the multivalent display of sperm protein fertilinb [1]. Here,
we demonstrate the value of ROMP chemistry for dis-
cerning the optimal fertilinb ligand presentation.
Fertilinb is located in the equatorial region of the sperm
head and is involved in sperm binding to the egg plasma
membrane during fertilization [2–5]. Fertilinb is a member
of the ADAM (a disintegrin and a metalloprotease do-
main) family of proteins [6]. A tripeptide, Glu-Cys-Asp
(ECD), is the minimal recognition element necessary for
the binding of fertilinb to its egg receptor [7–10]. This rec-
ognition motif is taken from the sperm protein’s disinte-
grin loop. Peptides containing the ECD motif inhibit
*Correspondence: nicole.sampson@stonybrook.edusperm-egg adhesion in vitro [1, 7, 8, 11–13]. For example,
the IC50 for inhibition of fertilization by the ECD monomer
1 is w500 mM. Peptides containing this sequence have
been assayed in a diverse range of species, and the pep-
tides inhibit fertilization in all of them [7, 8, 12, 14–16].
Thus, ECD is a small pharmacophore around which in-
hibitors of fertilization may be designed.
Regardless of their length or flanking sequence, all
monomeric ECD peptides are poor inhibitors. Knowing
that multivalent display of ligands often improves their
affinity [17–20], we developed multivalent presentations
of the ECD ligand [1, 13, 21]. Liposomes presenting eight
copies of the ECD ligand are 100-fold better inhibitors
than the corresponding monomer [13, 21]. Polymers
containing ten copies of the ECD motif, e.g., 210, show
50- to 70-fold increased inhibition over the correspond-
ing monomer [1]. These are the highest potencies re-
ported to date for an ECD inhibitor. Incorporation of a
fluorophore into the probes established that the target of
the polyvalent ECD inhibitors is on the surface of the
egg, and not on the sperm surface [21, 22]. Previously,
we synthesized an 125I-labeled DECD peptide, which
both inhibited fertilization, and photoaffinity-labeled in-
tegrin a6b1 [23]. Several other laboratories have also re-
ported integrin a6b1 as being the receptor [12, 24, 25].
However, Myles and coworkers have established that
mice with a conditional b1 integrin knockout in the egg
are fertile [26], and that a6 null eggs are still fertilized by
wild-type sperm [27]. Little information has been ob-
tained about the differences of the egg surface proteome
between the integrin knockout eggs and wild-type eggs
because of the extraordinarily small amounts of protein
material that may be obtained. Clearly, chemical
methods that can be used to investigate the proteome
are required. In this work, we advance ROMP of pep-
tide-bearing monomers to define the optimal presenta-
tion of ECD ligands for future development of proteome
probes that are of high affinity and that have useful
handles for identification of cell surface receptors and
coreceptors.
We employed ruthenium-catalyzed ROMP [28] for sev-
eral reasons. Using ROMP, it is possible to prepare poly-
mers of well-defined length. Ruthenium catalysts are
very stable, readily available, and functional group toler-
ant. In addition, ROMP allows for the multivalent presen-
tation of one or more functional groups along a polymer
backbone. Monomer building blocks are constructed
from strained cyclic alkenes—in our case, 5-norbor-
nene-exo-carboxylic acid. The utility of ROMP is that
one can easily manipulate the length of a polymer by
varying the monomer:catalyst ratio. Moreover, the phar-
macophore density of a polymer is readily adjusted by
feeding two simple monomer building blocks, one
a pharmacophore and one a spacer, to the catalyst in
varying ratios. The pharmacophore and spacer may be
mixed in a random fashion [29–31]. In this work, we
take advantage of the living nature of the polymerization
catalyst to prepare block copolymer. Thus, using one
or two simple monomer building blocks and ROMP
chemistry, a family of polymers may be generated to
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252Figure 1. Polymers Synthesized by ROMP and Tested as Fertilization Inhibitors
The compound number refers to the structure of the ligand. The subscript to the compound number refers to the number of that specific
monomer in the polymer. Refer to Figure 2 for a cartoon representation of the polymer structures.determine the length and spacing requirements for
maximal polymer affinity or avidity.
We synthesized a family of structurally diverse fertilinb
peptide polymers derived from 210 by using a combina-
tion of solution-phase peptide synthesis and ROMP to
define the best inhibitor structure (Figure 1). Polymers
310, 370, 410, 470, 38/472, 33, 36, and 32-47-32 were tested
as inhibitors in a mouse in vitro fertilization assay. These
polymers were chosen to present a diversity of size and
densities to the egg. With their assay, we explored the
role of inhibitor length and pharmacophore spacing.
The chemical approach developed here is general and
will be of use for exploring receptor-ligand interactions
in many different biological systems.
Results
Synthesis of Polymers
The peptide monomers 3 and 4 were synthesized by
using standard solution-phase procedures with t-butyl/
trityl-based side chain protection and Fmoc/Cbza-amino
protection. Solution-phase methods were used in order
to obtain large quantities of pure peptide for ROMP.
Polymers were prepared by ROMP by using fully pro-
tected peptides and (H2IMes)(PCy3) Cl2Ru=CHPh or
(H2IMes)(3-Br-pyr)2Cl2Ru=CHPh as the catalyst in
dichloromethane/methanol (3/1)with3 M LiCl tosolubilize
the polymer as previously described (Figure 1) [32]. Poly-
mers were deprotected with a trifluoroacetic acid/water/
triisopropylsilane cocktail and were precipitated with di-
ethyl ether. They were reduced with tris(2-carboxyethyl)-
phosphine, precipitated with dilute acid, and resus-
pended in aqueous ammonium hydroxide at pH 7
before use in assays. Isolated yields were 63%–95%. In-
tegration of NMR spectra confirmed that the numberof monomers incorporated into each polymer was the
same as the initial monomer:catalyst ratio. Gel perme-
ation chromatography (GPC) was used to analyze and
monitor the molecular weight distribution of the polymer
block intermediates in the synthesis of 32-47-32. The syn-
thetic precursors 32
0and 320-470 and product 320-470-320
wereanalyzedwith sidechainprotection intact (Figure 2).
For each reaction, the disappearance of the monomer
was monitored by TLC before addition of the subsequent
monomer. Then, a portion of the polymerization reaction
was quenched with ethylvinyl ether after each monomer
addition for analytical purposes. The three protected
polymers were analyzed by 1H-NMR spectroscopy,
and their monomer compositions corresponded to the
monomers fed to the polymerization reaction. GPC of
32
0, 320-470, and 320-470-320 confirmed that none of the
precursor block remained after addition of the subse-
quent monomer, and that the number-average molec-
ular weights shifted as expected (Figure 2). The final
triblock copolymer 32
0-470-320 had a narrow polydisper-
sity index of 1.21, consistent with a controlled, living
polymerization.
Assay of Polymers
Polymers were assayed as inhibitors in a mouse in vitro
fertilization assay. Sperm fusion was used as an end-
point to measure inhibition of sperm binding. Two mea-
sures of fertilization were calculated: fertilization rate
(FR) and fertilization index (FI) [7]. The FR is the total num-
ber of eggs fertilized divided by the total number of eggs.
The FI is the total number of sperm fused divided by the
total number of eggs. Inhibitor concentrations were var-
ied over at least a 400-fold range to determine their IC50s
by both FR and FI. Concentrations were considered both
in peptide ligand and in polymer (Table 1). For example,
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253Figure 2. Gel Permeation Chromatography Characterization of Block Copolymer
Comparison of GPC-eluted peaks of 32
0, 320-470, and 320-470-320 was performed by using a Phenogel column (5m, 300 3 4.6 mm, linear mixed
bed, 100–106 MW range) eluting with 0.3 ml/min 10% MeOH in CH2Cl2. Narrowly dispersed polystyrene standards were used to calibrate num-
ber-averaged molecular weight. Polymer 32
0 eluted at an apparent Mn of 3,372 (PDI: 1.18; expected MW: 1,812), polymer 320-470 eluted at an
apparent Mn of 10,840 (PDI: 1.18; expected MW: 5,673), and the triblock copolymer 32
0-470-320 has an apparent Mn of 15,013 (PDI: 1.21;
expected MW: 7,382).a 10 mM (in polymer) solution of 310 contains 100 mM ECD
ligand. Peptide ligand concentrations are useful for com-
paring the inhibition efficiencies of polymers containing
different numbers of ligands.
Sperm Susceptibility to Polymers
Sperm were allowed to capacitate and acrosome react
and were then treated with polymer and observed under
a light microscope. The percentage of live, motile sperm
remaining after 45 min was the same in control incuba-
tions and in 500 mM polymer incubations (70% 6 7%
for 310, 76% 6 11% for 370, 74% 6 11% for 32-47-32,
and 74% 6 8% for the control). Sperm were also incu-
bated with 125 mM 32-47-32 for 45 min prior to insemina-
tion of eggs. In these experiments, the final concentra-
tion of 32-47-32 in the sperm-egg incubation buffer wasbelow the IC50. There was no difference in FR or FI with
pretreated sperm compared to fertilization by control
sperm that were incubated in buffer alone (Figure 3).
Lastly, no inhibition was observed in the presence of
500 mM negative control polymers 410 or 470 (Table 1).
Discussion
Understanding protein-protein interactions in fertiliza-
tion is of fundamental importance for elucidating the
molecular display required for biological function. How-
ever, this biological system is not amenable to many
methods typically used to probe protein interactions—
for example, phage display or mutagenesis of intact
egg proteins—because of the limited quantities of mate-
rial available to study gametes in mammalian systemsTable 1. Polymer IC50s for Inhibition of In Vitro Fertilization
Polymer IC50 (mM) in Peptide by FI
a IC50 (mM) in Peptide by FR IC50 (mM) in Polymer by FI IC50 (mM) in Polymer by FR
1 (monomer) >500b >500b n.a.c n.a.
210 5.1 6 1.4 5.8 6 0.3 0.51 6 0.14 0.58 6 0.03
310 3.4 6 0.3 3.2 6 0.2 0.34 6 0.03 0.32 6 0.02
370 68 6 11.1 99 6 31 0.97 6 0.16 1.4 6 0.44
38/472 23 6 5 80 6 24 2.9 6 0.7 10 6 4
410 n.i.
d n.i. n.i. n.i.
470 n.i.
d n.i. n.i. n.i.
33 w500
e w500e w167 w167
36 w500
f w500f w83 w83
32-47-32 1.1 6 0.3 5.5 6 2.3 0.28 6 0.08 1.4 6 0.6
a FI (fertilization index) is the average number of fused sperm per egg. The average FI of the control was 1.93. FR (fertilization rate) is the percent-
age of eggs fertilized. The average FR of the control was 85.7%. A total of 200–300 eggs were assayed for each polymer in 8–10 independent
experiments. IC50s were calculated by a three parameter fit (GRAFIT software) by using the equation: percent fertilization = (100 2 b)/{1 + ([I]/
IC50)}
s, where b is the remaining percent fertilization after saturation with inhibitor, and s is the slope of the fit. Errors are reported as SEM.
b At 500 mM 1, 29% (F.I.) and 32% (F.R.) were observed.
c n.a.: not applicable.
d n.i.: no inhibition. Negative control polymers 410 and 470 did not inhibit fertilization at 500 mM (peptide).
e At 500 mM 33 (peptide), the percent inhibition observed was 66 6 9 (FI) and 58 6 2 (FR).
f At 500 mM 36 (peptide), the percent inhibition observed was 57 6 5 (FI) and 52 6 4 (FR).
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ROMP chemistry in order to advance our understanding
of fertilization with polymer probes.
Previously in our laboratory, we demonstrated that
a norbornyl polymer displaying the peptide sequence
ECDVT, 210, is a significantly more potent inhibitor of fer-
tilization than a simple monomeric peptide [1]. The first
step to optimize polymer structure was to simplify the
ligand appended to the polymer backbone. We prepared
and tested 310 and compared its potency to that of 210.
Inhibition by 310 was equipotent to that of 210 (Table 1).
These results demonstrate that, as expected, removal
of valine and threonine to shorten the ligand sequence
to ECD did not impair inhibition. The polymer behaved
similarly to 210. The shorter ligand improved solubility
of the ROMP monomer precursors, as well as the poly-
mer, and reduced the number of synthetic steps re-
quired.
In order to be certain that the inhibition observed was
caused by the ECD binding motif, we prepared control
polymers 410 and 470 with the mutant sequence ESA.
We chose to mutate ECD rather than scramble it because
two of the amino acids contain carboxylates. We were
concerned that scrambling the peptide might not com-
pletely eliminate binding, and that multivalent presenta-
tion would restore significant inhibition. We chose to mu-
tate cysteine and aspartate because mutagenesis work
by White and coworkers [33] and Evans and coworkers
[9] showed that these residues were critical for binding.
We retained the glutamate residue for solubility reasons.
No inhibition of fertilization by polymers 410 and 470 was
observed at polymer concentrations of 50 and 8 mM, re-
spectively. Thus, the inhibition by 310 observed is due to
a specific interaction of the ECD peptide with a cell sur-
face molecule.
Figure 3. Assay of Sperm Susceptibility to Polymers
Sperm were incubated with 32-47-32 (125 mM in peptide) or M16
buffer for only 45 min prior to egg insemination (final 32-47-32 con-
centration was w2 mM in peptide). The 32-47-32-pretreated sperm
and control sperm fertilized eggs equally efficiently, as measured
by both fertilization rate (FR) and fertilization index (FI), demonstrat-
ing that the polymer does not have an adverse affect on the sperm.
A total of 60 eggs were used in 3 independent experiments. Errors
are reported as standard error of measurement.Previous work had demonstrated that fluorescently la-
beled polymer210binds to the surface of the egg, and not
the sperm surface [22]. We tested whether the inhibition
observed could be due to deleterious effects of polymer
upon sperm. Polymers that only contained ESA peptide
substituants, e.g., 410 and 470, showed no inhibition of
fertilization. Incubation of sperm with ECD-containing
polymers did not affect their motility or viability. Sperm
pretreated with polymer 32-47-32 before insemination in
M16 buffer were able to fertilize eggs normally (Figure 3).
Therefore, treatment of sperm with our polymers does
not affect sperm viability, motility, or penetrability. Tar-
geting of the ECD polymers for the egg cell surface is
responsible for inhibition.
A longer polymer should cluster many more receptors
on the oocyte and have a statistical advantage that fa-
vors rebinding of ligand over dissociation; therefore, lon-
ger polymers should be a more potent sperm inhibitors.
For example, in studying glycopolymer inhibition of
hemagglutination, Kanai and coworkers have shown
that inhibition potency (as measured on a per residue
basis) saturates at a length of about 50 residues [18]. Inhi-
bition potency does not decrease as the polymer length
increases beyond the length required to span binding
sites as would be expected if only chelation were impor-
tant [18]. Hence, we synthesized polymer 370, which
contained approximately 70 ECD ligands, and polymer
38/472. Polymer 38/472 was approximately the same
length as polymer 370, but only 10% of the peptides pre-
sented (randomly) were the ECD ligand; the remainder
were the ESA mutant sequence. To our surprise, we ob-
served that the longer polymers showed decreased inhi-
bition potency compared to 310 when compared on the
basis of peptide concentration (Table 1). When com-
pared on the basis of polymer concentration, 310 and
370are essentially equipotent, and38/472 is less effective.
Previous investigations had demonstrated that if the
cysteine residue of the ECD sequence is protected as
a disulfide, no inhibition is observed [8, 10]. We investi-
gated the rate of thiol oxidation in the polymers under
the conditions of the in vitro fertilization assay. If signifi-
cant oxidation of the polymer thiols were to occur faster
in the longer polymers, their potency would be reduced
compared to the shorter polymers. We measured re-
duced thiol concentration as a function of time by using
5,50-dithiobis(2-nitrobenzoic acid) [34] in M16 buffer at
37ºC. For all of the polymers, less than 20% of the thiols
were oxidized over the 45 min incubation period of the
assay, and the oxidation rate of 310 did not differ signifi-
cantly from the oxidation rates of 370 and 38/472.
We concluded that increasing the number of ligands
presented and/or increasing the distance between li-
gands did not improve inhibitor potency. Our data imply
that chelation of the receptor is more important than sta-
tistical factors favoring ligand rebinding. A polymer
length of ten represented the maximum length required
for efficient inhibition. When modeled in the most ex-
tended backbone configuration (trans-syndiotactic), the
distance spanned by 310 is at most 5.3 nm. We next
sought to determine the minimum length of polymer
required for inhibition.
We synthesized fully substituted ECD ligand 3-mers
and 6-mers. Polymers 33 and 36 were both poor inhibi-
tors, and they showed no more potency than the ECD
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255Figure 4. Relative Potencies of Fertilinb Polymers When Compared on the Basis of Peptide Ligand Concentrationmonomer 1. These results indicated that multivalency
was required for effective binding and inhibition, and
that the 3-mer and 6-mer did not have sufficient length
to span the distance between binding sites of two adja-
cent receptors. In the most extended configuration, 36
can, at most, span 3 nm.
The poor inhibition of fertilization by polymer 36 im-
plied that the potency of 310 was due to the ligation of
the terminal ECD moieties, and that the internal ECD
peptides did not engage receptor binding sites. The liv-
ing nature of the ROMP polymerization allows for the se-
quential addition of monomer building blocks to the
growing polymer chain. We took advantage of this poly-
mer property to construct 32-47-32, which contained, on
average, two ECD ligands at either terminus separated
by a 7-mer spacer comprised of biologically inactive
ESA peptides. The block nature of the polymer was ver-
ified by gel permeation chromatography (GPC) analysis
of 32
0-470-320 as well as the monoblock and diblock pre-
cursors (Figure 2). There were no low molecular weight
shoulders on the 32
0-470-320 peak, confirming that the
polymerization was living, and that the intact triblock
polymer had been prepared.
The inhibition potency of polymer 32-47-32 was equal
to that of polymer 310 in polymer concentration, and it
was slightly better when compared on the basis of pep-tide concentration. We conclude that the internal ECD
ligands in polymer 310 are not required for binding or
inhibition (Figure 4). The distance between ECD ligands
on an extended 9-mer isw4.7 nm, and on an extended
10-mer, it is w5.3 nm, indicating that the distance be-
tween receptor binding sites can be no greater than
5 nm (Figure 5). Typically, membrane protein receptors
are 2–3 nm in diameter. Based on the ineffective inhibi-
tion observed with polymer 36, fertilinb receptor binding
sites are more than 3 nm apart. Taken together, our poly-
mers appear to engage the egg surface receptor in a
bivalent fashion (Figure 5).
Our results are analogous to other systems in which
bivalent inhibitors show high selectivity and affinity. For
example, Portoghese and coworkers designed bivalent
ligands for the opioid receptors [35]. Their results are
consistent with a model in which two receptors are re-
cruited into van der Waals contact,w3 nm apart. Potent
proteasome inhibitors have been designed by using
a similar strategy. Moroder and coworkers [36, 37] syn-
thesized inhibitors containing two Arg-Leu-Arg peptides
spaced by a 6.5 nm polyethylene glycol linker. The biva-
lent inhibitor was 124-fold more potent than the mono-
meric peptide. Potent inhibition required a linker that
was flexible and long enough to span the distance be-
tween the active b subunits of the proteosome.Figure 5. Proposed Model for Receptor-
Polymer Binding
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lent inhibition model like that of the opioid receptor or
the proteosome. Using block synthesis of copolymers,
we conclude that inhibition of fertilization by fertilinb
mimics requires recruitment of two receptors on the
egg surface into an inhibitory complex. The recruitment
of additional receptors with longer polymers does not en-
hance inhibition potency. These experiments establish
the parameters for future polymer design and testing.
The structural requirements defined here will be incorpo-
rated into future polymers that include tagging elements
for probing the identity of egg surface fertilinb receptors.
Significance
Themechanisms by which spermatozoa bind and fuse
to the oocyte plasma membrane during mammalian
fertilization are still unknown. In this work, we utilized
the fertilinb binding site peptide ECD to define the mo-
lecularstructure required foroptimal inhibitionof invitro
fertilization, a measure of sperm-egg binding. Using
two simple monomeric building blocks, a diverse se-
ries of polymers was synthesized by ring-opening po-
lymerization (ROMP) of norbornene. We introduce
block copolymer synthesis as a method by which to
optimize polymer potency and to rapidly identify re-
quiredspacer lengths. Inourpolymer series, the length
of spacer between ECDpharmacophores and the num-
bers of ECD pharmacophores presented to the egg
were varied. Polymers tested contained as few as 3
ECD ligands and as many as 70 ECD ligands. The
most potent fertilinb-derived inhibitor of fertilization
to date is an 11-mer polymer that contains two ECD li-
gands at either terminus separated by seven spacer
monomers. These results indicate that two ECD li-
gands bound to the egg surface separated by 4–5 nm
are sufficient for maximal inhibition. Definition of the
optimal polymer structure for inhibition now allows
for the design of molecular probes to identify the egg
cell surface members of the inhibitory complex.
Experimental Procedures
Materials
Amino acids and coupling agents used were purchased from
Advanced Chem Tech. (Louisville, KY) or PerSeptive Biosystems
(Framingham, MA). Solvents and chemical reagents were obtained
from Fisher Scientific, Inc. (Springfield, NJ) or Sigma-Aldrich
(Milwaukee, WI). Pregnant mare’s serum gonadotropin (PMSG,
#367222), hyaluronidase (#H3506), and Hoechst-33342, were pur-
chased from Sigma-Aldrich, and human chorionic gonadotropin
(hCG, #230734) was obtained through the National Hormone and
Peptide Program, the National Institute of Diabetes and Digestive
Kidney Diseases, and Dr. A.F. Parlow. (H2IMes)(PCy3)Cl2Ru=CHPh
was purchased from Sigma-Aldrich (Milwaukee, WI). (H2IMes)(3-Br-
pyr)2Cl2Ru=CHPh was prepared according to the literature [38].
CH2Cl2 was freshly distilled from CaH; CH3OH and Et2O, were used
without further purification. LiCl was oven dried and stored over
P2O5 before use. All reactions were carried out under an Ar atmo-
sphere in oven-dried glassware unless otherwise specified. Moisture
and oxygen-sensitive reagents were handled in an N2-filled drybox.
5-Norbornene-exo-carboxylic acid was synthesized according to
the literature [19].
General Methods
Analytical thin layer chromatography (TLC) was performed on pre-
coated silica gel plates (60F254) and flash chromatography on silicagel-60 (230–400 mesh). TLC spots were detected by UV light and by
staining with phosphomolybdic acid (PMA). Peptides were purified
by flash column chromatography on silica gel-60. The purities of all
peptide monomers were assessed by RPHPLC by using a Vydac
C18 column. Gradient elution was performed at 1 ml/min with aceto-
nitrile and water (both containing TFA, 0.1%). The purity of the poly-
mers was assessed by aqueous-phase gel permeation chromatogra-
phy (BioSep-SEC-S2000) by using 50 mM potassium phosphate (pH
7). Inova400, Inova500, and Inova600 MHz NMR spectrometers were
used to perform NMR analysis, and spectra were recorded in CDCl3
unless otherwise noted. 1H-NMR spectra are reported as chemical
shift in parts per million (multiplicity, coupling constant in Hz, integra-
tion). 1H-NMR data are assumed to be first order. Copies of spectra
are available in the Supplemental Data with this article online. The
usual workup for peptide coupling reactions was three washes of
the CH2Cl2 solution with 5% NaHCO3, followed by three washes
with 1 N HCl and drying of the CH2Cl2 over Na2SO4. After evaporation
of solvent, the peptide product was purified by flash silica chroma-
tography.
PMSG and hCG were resuspended in sterile PBS to 10 IU/100 ml.
These solutions were stored at 220ºC. Hyaluronidase was resus-
pended in sterile water to a final concentration of 30 mg/ml and
was stored at 220ºC. Hoechst-33342 was stored in the dark at 4ºC.
All of the steps involving the use of Hoechst dye were performed
with minimum exposure to light.
Fmoc-Cys(trt)Asp(OtBu)-OMe
H-Asp(OtBu)-OMe$HCl (16.69 mmol, 4.00 g), Fmoc-Cys(trt)-OH
(18.36 mmol, 10.75 g), EDC$HCl (20.03 mmol, 3.83 g), and HOBt$hy-
drate (20.03 mmol, 3.07 g) were dissolved in 40 ml dry CH2Cl2 and
cooled to 0ºC. DIEA (18.36 mmol, 3.25 ml) was added, and the reac-
tion was stirred for 4 hr at room temperature. The usual workup and
chromatography (acetone:CH2Cl2/1:20) yielded Fmoc-Cys(trt)As-
p(OtBu)-OMe (12.7 g, 98%) as a white powder. 1H-NMR (400 MHz)
d 7.74 (t, J = 7.6 Hz, 2), 7.57 (d, J = 4.8 Hz, 2H), 7.31 (m, 19H), 6.78
(d, J = 7.6 Hz, 1H), 5.01 (d, J = 6.8 Hz, 1H), 4.71 (m, 1H), 4.34 (m, 2H),
4.19 (t, J = 7.0 Hz, 1H), 3.76 (dd, J = 6.8, 6.8 Hz, 1H), 3.66 (s, 3H),
2.89 (dd, J = 17.0, 4.6 Hz, 1H), 2.73 (m, 1H), 2.65 (m, 2H), 1.38 (s, 9H).
Fmoc-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe
Fmoc-Cys(trt)Asp(OtBu)-OMe (5.19 mmol, 4.00 g) was dissolved in
10 ml dry CH2Cl2. 1-Octanethiol (51.9 mmol, 9.04 ml) and DBU (0.52
mmol, 78 ml) were added, and the reaction was stirred for 15 hr at
room temperature under Ar. After evaporation of the solvent, the
resulting product was purified by flash chromatography eluting
with a step gradient ranging from 2% to 50% EtOAc/CH2Cl2. H-Cys
(trt)Asp(OtBu)-OMe (2.09 g, 73%) was obtained as a fine white
powder. H-Cys(trt)Asp(OtBu)-OMe, (3.65 mmol, 2.00 g), Fmoc-
Glu(OtBu)-OH (4.02 mmol, 1.71 g), EDC$HCl (4.38 mmol, 0.84 g),
and HOBt$hydrate (4.38 mmol, 0.67 g) were dissolved in 10 ml dry
CH2Cl2 and were cooled to 0ºC. DIEA (4.02 mmol, 0.71 ml) was added,
and the reaction was stirred for 5 hr at room temperature. The
usual workup and chromatography (acetone:CH2Cl2/1:20) yielded
Fmoc-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe (3.04 g, 87%) as a white
powder. 1H-NMR (400 MHz) d 7.76 (d, J = 7.6 Hz, 2H) 7.56 (t, J = 7.2
Hz, 2H), 7.40 (m, 8H), 7.28 (m, 8H), 7.18 (m, 3H), 6.90 (d, J = 8.4 Hz,
1H), 6.61(d, J = 7.6 Hz, 1H), 5.84 (d, J = 6.4 Hz, 1H), 4.72 (m, 2H),
4.35 (d, J = 7.2 Hz, 2H), 4.15 (m, 2H), 4.04 (m, 1H), 3.67 (s, 3H), 2.82
(m, 2H), 2.67 (dd, J = 17.0 and 4.8 Hz, 1H), 2.57 (dd, J = 13.2 and 5.2
Hz, 1H), 2.40 (m, 1H), 2.30 (m, 1H), 2.03 (m, 1H), 1.88 (m, 1H), 1.44
(s, 9H), 1.40 (s, 9H).
Ac-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe
Fmoc-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe (0.31 mmol, 300 mg) was
dissolved in 1 ml dry CH2Cl2. 1-Octanethiol (3.14 mmol, 546 ml) and
DBU (0.031 mmol, 30 ml) were added, and the reaction was stirred
for 16 hr at room temperature. The resulting product was purified
by flash chromatography eluting with a step gradient ranging from
2% to 50% EtOAc/CH2Cl2. H-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe
(163 mg, 72%) was obtained as a fine white powder. H-Glu(OtBu)-
Cys(trt)Asp(OtBu)-OMe (0.27 mmol, 198 mg) was dissolved in 3 ml
dry CH2Cl2. Acetic anhydride (2.70 mol, 257 ml) was added to the re-
action and was followed by DIEA (0.82 mmol, 114ml), and the reaction
was stirred for 1 hr at room temperature under Ar. The usual workup
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257and recrystallization of the crude product from CH2Cl2 yielded Ac-
Glu(OtBu)Cys(trt)Asp(OtBu)-OMe (163 mg, 78%) as a white powder.
1H-NMR (400 MHz) d7.42 (m, 6H) 7.30 (m, 6H), 7.21 (m, 3H), 6.86 (d, J =
8.4 Hz, 1H), 6.70 (d, J = 7.6 Hz, 1H), 5.53 (d, J = 6.8 Hz, 1H), 4.70 (m, 1H),
4.33 (m, 1H), 4.01 (m, 1H), 3.67 (s, 3H), 2.84 (dd, J = 16.8 and 5.2 Hz,
1H), 2.77 (dd, J = 13.2 and 8.0 Hz, 1H), 2.67 (dd, J = 16.8 and 4.8 Hz,
1H), 2.58 (dd, J = 12.8 and 5.2 Hz, 1H), 2.40 (m, 1H), 2.28 (m, 1H),
2.03 (m, 1H), 1.97 (s, 3H), 1.88 (m, 1H) 1.43 (s, 9H), 1.40 (s, 9H). ESI
mass spectrum: Calcd (MNa+) 798.35; Found 798.52.
Ac-GluCysAsp-OMe, 1
Ac-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe was deprotected in a cocktail
of H2O, TIPS, and TFA (2.5:2.5:95) for 5 hr. The reaction mixture
was concentrated with N2 and precipitated with cold Et2O. The pre-
cipitate was dissolved in 10% acetonitrile in H2O, and it was reduced
with DTT (10 mM) for 1 hr with stirring at 37ºC. Pure deprotected
product was isolated as a white solid by reversed-phase C18 HPLC
(1 cm 3 30 cm, 5 m) by using 0.1% TFA/H2O and a linear gradient of
CH3CN. ESI mass spectrum: Calcd (MH
+) 420.12; Found 420.16.
NB-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe, 3
H-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe (0.22 mmol, 163 mg), 5-norbor-
nene-exo-carboxylic acid (0.24 mmol, 34 mg), TBTU (0.24 mmol, 78
mg), and HOBt$hydrate (0.08 mmol, 13 mg) were dissolved in 2 ml
dry CH2Cl2. DIEA (0.24 mmol, 43 ml) was added, and the reaction
was stirred for 1 hr at room temperature. The usual workup and chro-
matography (acetone:CH2Cl2/1:20) yielded 3 (144 mg, 76%) as
a white powder. 1H-NMR (400 MHz) d 7.41 (m, 6H) 7.29 (m, 6H), 7.21
(m, 3H), 6.94 (d, J = 8.4 Hz, 1H), 6.73 (m, 1H), 6.67 (m, 1H), 6.11 (m,
1H), 6.02 (m, 1H), 4.72 (m, 1H), 4.29 (m, 1H), 4.04 (m, 1H), 3.67 (s,
3H), 2.92 (m, 1H), 2.83 (m, 3H), 2.70 (m, 1H), 2. 48 (m, 2H), 2.29 (m,
1H), 2.02 (m, 2H), 1.88 (m, 4H), 1.64 (d, J = 7.2 Hz, 1H), 1.44 (d,
J = 5.6 Hz, 9H), 1.41 (s, 9H), 1.27 (m, 2H). 13C-NMR (400 MHz)
d 27.15, 27.21, 28.23, 28.28, 30.72, 30.77, 32.19, 32.24, 33.70, 33.77,
37.48, 41.78, 41.81, 44.77, 46.57, 46.63, 47.24, 47.39, 49.10, 52.39,
52.44, 52.69, 53.54, 53.64, 67.40, 81.43, 81.76, 127.11, 128.28,
128.29, 129.79, 136.08, 136.24, 138.34, 138.47, 144.58, 169.67,
169.94, 171.05, 171.36, 171.37, 173.68, 173.69, 176.58.
Cbz-Ser(tBu)Ala-OMe
H-Ala-OMe$HCl (27.20 mmol, 3.80 g), Cbz-Ser(tBu)-OH (29.91 mmol,
8.84 g), EDC$HCl (32.64 mmol, 6.26 g), and HOBt$hydrate (32.64
mmol, 5.00 g) were dissolved in 25 ml dry CH2Cl2 and were cooled
to 0ºC. DIEA (29.91 mmol, 5.30 ml) was added, and the reaction
was stirred for 12 hr at room temperature. The usual workup and
chromatography (acetone:CH2Cl2/1:20) yielded Cbz-Ser(tBu)Ala-
OMe (7.81 g, 76%) as a white powder. 1H-NMR (400 MHz) d 7.34
(m, 5H), 5.73 (m, 1H), 5.12 (m, 2H), 4.57 (m, 1H), 4.23 (m, 1H), 3.81
(m, 1H), 3.74 (s, 3H), 3.38 (t, J = 8.4 Hz, 1H), 1.40 (d, J = 7.2 Hz, 3H),
1.21 (s, 9H).
Cbz-Glu(OtBu)Ser(tBu)Ala-OMe
Cbz-Ser(tBu)Ala-OMe (1.62 mmol, 616 mg) was dissolved in 3 ml
MeOH. 10% Pd/C (0.16 mmol, 17 mg) was added, and the reaction
was stirred for 3 hr at room temperature under H2. After filtration of
the catalyst with celite, the resulting amine product was used without
further purification. H-Ser(tBu)Ala-OMe (1.62 mmol, 400 mg), Cbz-
Glu(OtBu)-OH (1.79 mmol, 604 mg), TBTU (1.34 mmol, 430 mg), and
HOBt$hydrate (0.45 mmol, 69 mg) were dissolved in 3 ml dry
CH2Cl2. DIEA (2.60 mmol, 460 ml) was added, and the reaction was
stirred for 12 hr at room temperature. The usual workup and chroma-
tography (acetone:CH2Cl2/1:20) yielded 8 (627 mg, 68%) as a white
powder. 1H-NMR (400 MHz) d 7.33 (m, 6H) 7.01 (d, J = 6.8, 1H), 5.72
(d, J = 6.4 Hz, 1H), 5.10 (m, 2H), 4.56 (q, 1H), 4.43 (m, 1H), 4.23 (m,
1H), 3.81 (m, 1H), 3.73 (s, 3H), 3.36 (t, J = 7.6 Hz, 1H), 2.38 (m, 2H),
2.12 (m, 1H), 1.95 (m, 1H), 1.43 (s, 9H), 1.39 (d, J = 7.2 Hz, 3H), 1.21
(s, 9H).
NB-Glu(OtBu)Ser(tBu)Ala-OMe, 4
Cbz-Glu(OtBu)Ser(tBu)Ala-OMe (0.53 mmol, 300 mg) was dissolved
in 3 ml MeOH. 10% Pd/C (0.053 mmol, 6 mg) was added, and the re-
action was stirred for 2 hr at room temperature under H2. After filtra-
tion of the catalyst with celite, the resulting amine product was used
without further purification. H-Glu(OtBu)Ser(tBu)Ala-OMe (0.51mmol, 220.0 g), 5-norbornene-exo-carboxylic acid (0.56 mmol, 78
mg), TBTU (0.56 mmol, 180 mg), and HOBt$hydrate (0.19 mmol, 29
mg) were dissolved in 3 ml dry CH2Cl2. DIEA (0.61 mmol, 108 ml)
was added, and the reaction was stirred for 3 hr at room temperature.
The usual workup and chromatography (acetone:CH2Cl2/2:10)
yielded 4 (226 mg, 74%) as a white powder. 1H-NMR (400 MHz)
d 7.38 (t, J = 8.0 Hz, 1H) 7.02 (t, J = 7.4 Hz, 1H), 6.82 (d, J = 5.6 Hz,
1H), 6.12 (m, 2H), 4.56 (q, 1H), 4.44 (m, 1H), 4.38 (m, 1H), 3.86 (m, 1H),
3.73 (s, 3H), 3.37 (m, 1H), 2.96 (m, 1H), 2.91 (m, 1H), 2.47 (m, 1H), 2.37
(m, 1H), 2.13 (m, 1H), 2.07 (m, 1H), 2.00 (m, 1H), 1.90 (m, 1H), 1.65
(m, 1H), 1.45 (d, J = 4.0 Hz, 9H), 1.41 (dd, J = 7.2 and 0.8 Hz,
3H), 1.35 (m, 2H), 1.19 (d, J = 4.8 Hz, 9H) 13C-NMR (400 MHz)
d 18.30, 27.47, 27.52, 28.23, 30.62, 30.79, 32.25, 41.74, 41.76, 44.62,
44.67, 46.51, 46.57, 47.22, 47.37, 48.38, 48.41, 52.45, 52.47, 53.24,
53.87, 53.89, 61.48, 74.13, 74.18, 81.32, 81.33, 136.12, 138.40,
169.86, 169.88, 171.35, 171.38, 173.07, 173.62, 176.54, 176.55.
ROMP
The procedure detailed below for polymer 310 is representative of the
procedure followed for synthesis of all of the homopolymers and the
random copolymer. Scale, yield, and spectra are presented for each
of the individual polymers. The number of ligands (n) is based on the
monomer:catalyst ratio used in the synthesis and confirmed by inte-
gration in the 1H-NMR spectra.
310
NB-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe 3 (82 mmol, 70 mg) was dis-
solved in 100 ml CH2Cl2/MeOH (3/1). To the reaction was added
oven-dried LiCl (1.2 mmol, 51 mg) and (H2IMes)(PCy3)Cl2Ru=
CHPh (8 mmol, 7 mg) dissolved in 50 ml CH2Cl2/MeOH (3/1) and an ad-
ditional 250 ml CH2Cl2/MeOH (3/1). The reaction was stirred for 3 hr.
Ethyl vinyl ether (1 ml) was added to quench the reaction, and the
mixture was stirred for an additional 40 min. After removing the sol-
vent, the residue was dissolved in CH2Cl2. The solution was washed
three times with H2O, dried with Na2SO4, concentrated by rotary
evaporation, and precipitated with cold Et2O. The product was iso-
lated by centrifugation and dried. Crude protected polymer was
deprotected with TFA/TIPS/H2O (95/2.5/2.5) for 5 hr. The reaction
mixture was concentrated with N2 and was precipitated with cold
Et2O. The precipitate was collected by centrifugation. Polymer was
dissolved in H2O (1 ml) at pH 6 and reduced with 10–20 mM tris(2-car-
boxyethyl)phosphine (TCEP) for 2 hr at 37ºC. Reduced polymer was
isolated by precipitation with 1 N HCl (200 ml). Residual TCEP was
removed by repeated washing of the precipitate with H2O (3 3 1
ml). 310, a yellowish-white solid, was collected (41 mg, 90%), dried,
and stored at 220ºC. 1H-NMR (400 MHz, D2O) d 7.24 (m) 5.34 (m),
4.65–4.05 (with max at 4.61, 4.42, 4.23), 3.61 (br s), 2.90–2.29 (with
max at 2.80, 2.58, 2.45, 2.25), 2.22–1.45 (with max at 2.142, 1.86,
1.78), 1.18 (br s).
33
NB-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe 3 (82 mmol, 70 mg) and
(H2IMes)(3-Br-pyr)2Cl2Ru=CHPh (27 mmol, 24 mg) in a total volume
of 400 ml yielded 33 as a brownish-white solid (30 mg, 82%).
1H-
NMR (500 MHz, D2O) d 7.26 (m) 5.35 (m), 4.65–4.01 (with max at
4.55, 4.26, 4.04), 3.24 (br s), 2.90–2.29 (with max at 2.81, 2.51), 2.22–
1.45 (with max at 2.12, 1.93, 1.78), 1.19 (m).
36
NB-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe 3 (82mmol, 70 mg) and (H2IMes)
(3-Br-pyr)2Cl2Ru=CHPh (14 mmol, 12 mg) in a total volume of 400 ml
yielded 36 as a brownish-white solid (45 mg, 95%).
1H-NMR (500
MHz, D2O) d 7.26 (m) 5.45–5.10 (with max at 5.36, 5.29, 5.26), 4.65–
4.05 (with max at 4.59, 4.45, 4.27), 3.64 (br s), 2.90–2.45 (with max at
2.83, 2.63), 2.22–1.45 (with max at 2.21, 1.94, 1.84, 1.61), 1.21 (m).
370
NB-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe 3 (17 mmol, 15 mg) and (H2IM-
es)(PCy3)Cl2Ru=CHPh (0.17 mmol, 0.15 mg) in a total volume of 150
ml CH2Cl2/MeOH (3/1) yielded a yellowish-white solid (8 mg, 80%).
1H-NMR (400 MHz, D2O) d 7.20 (m), 5.23 (m), 4.44–4.09 (with max at
4.39, 4.08), 3.67 (br s), 3.22 (s), 3.15–1.45 (with max at 2.95, 2.80,
2.10, 1.91, 1.81, 1.60), 1.38–1.79 (with max at 1.23, 1.15, 0.90).
410
NB-Glu(OtBu)Ser(tBu)Ala-OMe 4 (38 mmol, 21 mg) and (H2IMes)(P-
Cy3)Cl2Ru=CHPh (13.8 mmol, 3.3 mg) in a total volume of 200 ml
CH2Cl2/MeOH (3/1) yielded 410 as a brownish-white solid (10 mg,
67%). 1H-NMR (600 MHz, D2O) d 4.29 (m), 5.23 (br, s), 4.29 (m), 4.00
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258(m), 3.65 (br, s), 3.20 (s), 3.10–2.30 (with max at 2.80, 2.45), 2.25–1.40
(with max at 2.10, 1.90, 1.79, 1.45), 1.20 (m), 1.00 (m).
470
NB-Glu(OtBu)Ser(tBu)Ala-OMe 4 (47 mmol, 26 mg) and (H2IMes)(P-
Cy3)Cl2Ru=CHPh (0.47 mmol, 0.40 mg) in a total volume of 200 ml
CH2Cl2/MeOH (3/1) yielded 470 as a brownish-white solid (12 mg,
63%). 1H-NMR (600 MHz, D2O) d 7.20 (m), 5.80–5.20 (m), 3.45 (br, s),
2.2–1.4 (with max at 2.19, 1.99, 1.68), 1.38–0.80 (with max at 1.23,
1.15).
38/472
NB-Glu(OtBu)Cys(trt)Asp(OtBu)-OMe 3 (12 mmol, 10 mg), NB-Glu(Ot-
Bu)Ser(tBu)Ala-OMe 4 (106 mmol, 58 mg), and (H2IMes)(PCy3)Cl2Ru=
CHPh (1.17 mmol, 0.99 mg) in a total volume of 400 ml CH2Cl2/
MeOH (3/1) yielded 38/472 as a yellowish-white solid (36 mg, 73%).
1H-NMR (600 MHz, D2O) d 7.22 (m) 5.45–5.10 (with max at 5.34, 5.23,
5.16), 4.65 (br s), 4.39–4.05 (with max at 4.31, 4.04), 3.75 (br s), 3.63 (br
s), 2.85 (m), 2.48 (m), 2.22–1.41 (with max at 2.13, 1.90, 1.81, 1.60),
1.40–1.00 (with max at 1.31, 1.23, 1.12), 0.92 (br s).
32
0, 320-470, 320-470-320, 32-47-32
In three separate flasks, A, B, and C, peptide 3 (23 mmol, 20 mg) was
dissolved in 100 ml CH2Cl2/MeOH (3/1). Then, oven-dried LiCl (1.2
mmol, 51 mg) and (H2IMes)(3-Br-pyr)2Cl2Ru=CHPh (12 mmol, 10 mg)
dissolved in 50 ml CH2Cl2/MeOH (3/1) were added to each flask. The
reactions were stirred for 1.5 hr. To flask A, ethyl vinyl ether (2 ml)
was added, and the mixture was stirred for 40 min to quench the re-
action yielding 32
0. To flasks B and C, peptide 4 (82 mmol, 45 mg) dis-
solved in 250 ml CH2Cl2/MeOH (3/1) was added, and the reactions
were stirred for 1.5 hr. Ethyl vinyl ether (2 ml) was added to flask B,
and the mixture was stirred for 40 min to yield 32
0-470. Then, peptide
3 (23 mmol, 20 mg) dissolved in 250 ml CH2Cl2/MeOH (3/1) was added
to flask C, and the reaction was stirred for 2 hr. Ethyl vinyl ether (2 ml)
was added to quench the reaction, and the mixture was stirred for an
additional 40 min to yield 32
0-470-320. For each reaction, TLC was used
to confirm the complete disappearance of monomer before addition
of the next monomer. After removing the solvent from each of the
flasks, the residues were dissolved separately in CH2Cl2. The solu-
tions were washed three times with H2O and dried with Na2SO4,
and the products 32
0, 320-470, and 320-470-320 were precipitated with
cold Et2O. The precipitates were isolated by centrifugation and dried.
Each of the polymers was analyzed by gel permeation chromatogra-
phy by using a Phenogel column (5m, 300 3 4.60 mm, linear mixed
bed, 100–106 MW range). Elution was performed at 0.3 ml/min with
10% MeOH in CH2Cl2. Narrowly dispersed polystyrene standards
from Aldrich were used as molecular weight calibrants. The num-
ber-averaged and weighted average molecular weights were calcu-
lated from the chromatogram to determine the polydispersity index
(PDI).
32-47-32
Crude protected polymer 32
0-470-320 was deprotected with TFA/TIPS/
H2O (95/2.5/2.5) for 5 hr. The reaction mixture was concentrated with
N2, and the polymer was precipitated with cold Et2O and isolated by
centrifugation. The polymer was dissolved in H2O (1 ml) at pH 6 and
was reduced with 10–20 mM TCEP for 2 hr at 37ºC. Deprotected poly-
mer was isolated by precipitation with 1 N HCl (200ml). Residual TCEP
was removed by repeated washing with H2O (331 ml). 32-47-32,a yel-
lowish-white solid (40 mg, 88%), was collected, dried, and stored at
220ºC. 1H-NMR (500 MHz, D2O) d 7.26 (m) 5.35 (m), 4.40–4.01 (with
max at 4.35, 4.27, 4.22, 4.06, 4.04), 3.77 (br s), 3.65 (br s), 3.25 (br s),
2.90–2.29 (with max at 2.85, 2.51), 2.22-1.45 (with max at 2.16, 1.93,
1.84, 1.62), 1.34 (br s), 1.26–1.02 (with max at 1.25, 1.15), 0.94 (br s).
Assay for Thiol Oxidation
5,50-dithiobis(2-nitrobenzoic acid) (DTNB) was prepared as a 5 mM
stock solution in 100 mM potassium phosphate buffer solution (pH
7.2), containing 0.1 mM EDTA, and was stored in the dark at 4ºC.
All polymers were fully reduced with TCEP, washed three times
with deionized water, and dissolved in aqueous ammonium hydrox-
ide solution (pH 7.2). Aliquots of polymer (< 10 ml) were added to M16
(without BSA or phenol red) to a final volume of 100 ml and were incu-
bated at 37ºC. The final concentrations of polymer were 100, 75, and
50 mM, and 9 aliquots were prepared at each concentration. At 5 min
intervals for 45 min, 100 ml stock DTNB was added to a polymer ali-
quot, the solution was mixed, and the absorbance at 412 nm was
measured. The concentration of free sulfhydryl remaining was deter-mined by using 3412 = 14,150 M
21cm21 [34]. A standard curve for sulf-
hydryl concentration was prepared by using cysteine under the same
conditions.
Isolation of Spermatozoa and Oocytes for IVF Assay
All experiments performed with mice were in accordance with the
National Institute of Health and United States Department of Agricul-
ture guidelines, and the specific procedures performed were ap-
proved by the Stony Brook University IACUC (protocol #0616).
Sperm for the in vitro adhesion and fusion assay were isolated
from the cauda epididymis and vas deferens of 8-month-old ICR
retired male breeders (Taconic, NJ). Sperm were released from
dissected cauda and vas deferens into 3% BSA M16-modified
Krebs-Ringer medium. Released sperm were incubated at 37ºC,
5% CO2 for 3 hr in the same medium to allow them to capacitate
and acrosome react. Eggs were collected from the oviducts of 8-
to 10-week-old superovulated female ICR mice (Taconic, NJ). Mice
were superovulated by injecting 5 IU PMSG, followed 48–52 hr later
by an injection of 10 IU hCG. A total of 14–16 hr after hCG injection,
oviducts were removed from euthanized mice and were incubated
in prewarmed M16 medium with 0.5% BSA. Cumulus-egg com-
plexes were collected and transferred to 500ml drops of medium con-
taining 30 mg/ml hyaluronidase surrounded by mineral oil. After 5 min
of incubation at 37ºC, 5% CO2, cumulus-free metaphase II eggs
(eggs with one polar body) were collected, transferred first to a 80 ml
drop of medium, and then washed through six 40 ml drops of me-
dium. Eggs were recovered for 1 hr before treating with Tyrode’s
acid. Zona pellucida of metaphase II eggs were removed by treating
eggs with a 100 ml Tyrode’s acid drop for 1 min at room temperature.
Zona-free eggs were washed six times with 0.5% BSA medium and
were recovered for 2 hr, then preloaded with HOECHST dye at 10
mg/ml for 30 min at 37ºC, 5% CO2.
Inhibitor Assay
Before use, the polymers were fully reduced with 10 mM TCEP for 1–2
hr, precipitated with 1 N HCl, washed with water, and then redis-
solved in water adjusted to pH 7 with NH4OH.
Zona-free eggs that had been loaded with Hoechst dye were
washed and placed in 100 ml drops of 3% BSA M16 medium. Polymer
solution was added (no more than 5 ml of stock solution) and incu-
bated with eggs for 45 min prior to sperm addition. Capacitated
and acrosome-reacted sperm were added to eggs at a final concen-
tration of 1–5 3 105 sperm/ml. After 45 min at 37ºC, 5% CO2, eggs
were gently washed through six 40 ml drops of the M16 medium
with 3% BSA. Eggs were mounted onto glass microscope slides,
and sperm binding and fusion were scored by epi-fluorescence
microscopy and DIC microscopy (NIKON Eclipse 400, 403, 0.75 NA
objective). Fusion was scored as the fluorescent labeling of sperm
nuclei with HOECHST dye present in the preloaded eggs. Two mea-
sures of fusion were used: fertilization index (FI, mean number of
fused sperm per egg) and fertilization rate (FR, percentage of eggs
fused with at least one sperm). IC50s were calculated by a three
parameter fit (GRAFIT software) by the equation:
y = ð1002bÞ= 1 + ð I =IC50Þ g½ s;

(1)
where y is the percent FR or FI, b is the remaining percent fertilization
after saturation with inhibitor, and s is the slope of the fit. Errors were
reported as SEM.
Sperm Susceptibility to Polymer Assay
Sperm in 3% BSA M16-modified Krebs-Ringer medium were allowed
to capacitate and acrosome react in a 37ºC humidified incubator with
5% CO2 for 2 hr 30 min, then treated with 500 mM 310, 370, or 32-47-32
for 45 min. Control sperm were incubated in the same buffer. Sam-
ples were transferred to glass slides, and sperm motility and viability
were checked by light microscope (NIKON TS-100, 103, 0.25 NA ob-
jective). Only sperm that were still swimming actively were counted
as viable and motile. In a second experiment, sperm were incubated
for 45 min with 125 mM 32-47-32 in 3% BSA M16 buffer, or in medium
alone. A total of 2ml of the sperm incubation (1–53105 sperm/ml) was
transferred to a 100 ml M16 drop containing zona-free eggs. After 45
min, the eggs were analyzed for the number of sperm bound and
fused as previously described in the assay.
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Supplemental Data including NMR spectra are available at http://
www.chembiol.com/cgi/content/full/13/3/251/DC1/.
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